On June 15, the Bill & Melinda Gates Foundation announced its continued support to the Global Health Drug Discovery Institute (GHDDI), according to an official statement from the Beijing-based institute. The foundation will provide GHDDI with funds worth $50 million over the next five years for the development of life-saving drugs to treat infectious diseases, such as tuberculosis and malaria, which severely impact the world’s poorest populations, and contribute to global health improvement. GHDDI is an independently operated non-profit research institution focused on new drug research. It was established in 2016 through a collaborative effort involving the Beijing Municipal Government, the Bill & Melinda Gates Foundation, and Tsinghua University. The funding announcement coincided with the second day of Bill Gates’ visit to China. [Jiemian, in Chinese]